Our unique combination of custom antibody development, lateral flow development and manufacturing services, signal enhancement technology and our mobile diagnostic platform are shaping the future of lateral flow. Our partnership approach allows you to work with one company to reach your assay goals.
Discover our breadth of experience and be reassured that our Lateral Flow Development Services will deliver the best outcome for your assay.
BBI Solutions has over 25 years’ expertise working with customers and partners to develop and manufacture high quality proteins for a diverse range of applications with our Custom Protein Service.
BBI’s custom conjugation service allows us to develop high-quality conjugates using reagents provided by you or sourced by us.
BBI Solutions’ Novarum™ technology transforms a smartphone into a mobile diagnostic platform, empowering users to read and share the results of rapid tests at the point of care.
Gyrolab® Generic Cyno ADA Kit Reagents enable detection of anti-drug antibodies of human IgG or Fab in cynomolgus monkey matrix.
Enzyme Immunoassay for the Qualitative / Quantitative Screening of double stranded RNA in mRNA based preparations.
Immunoassay for the measurement of E.coli Host Cell Proteins
ELISA for the detection of Blinatumomab in human serum and plasma. Lead time for this kit is 5 weeks. About the kit: - Uses anti-idiotypic monoclonal antibodies sourced from our vendor partner in the US, which ensures higher specificity, and low cross reactivity. - Recovery rates are between 85 - 115% - Validated as per US FDA guidelines for Bioassays - Developed using the innovator drug as calibrator - Shelf life: 1 year
Enzyme Immunoassay for the Quantitative Determination of Faricimab in human serum and plasma.
Enzyme Immunoassay for the quantitative determination of Ocrelizumab in serum and plasma.
Enzyme Immunoassay for the quantitative determination of Pidilizumab in serum and plasma.
Enzyme Immunoassay for the Quantitative Determination of Relatlimab in human serum and plasma
Enzyme Immunoassay for the Quantitative Determination of Teclistamab in serum and plasma
Quantitative immunoassay for Ustekinumab
Enzyme Immunoassay for the quantitative determination of Erenumab in serum and plasma.
Enzyme Immunoassay for the quantitative determination of Guselkumab in serum and plasma.
Enzyme Immunoassay for the Quantitative Determination of Cemiplimab in human serum and plasma
Enzyme Immunoassay for the Quantitative Determination of Amivantamab in serum and plasma
Canakinumab (ILARIS) ELISA for quantitative determination of Canakinumab (ILARIS) in human serum
Enzyme Immunoassay for the Quantitative Determination of Teprotumumab in serum and plasma.
ELISA for the detection of Mosunetuzumab in human serum and plasma.
Enzyme Immunoassay for the Quantitative Determination of Darbepoetin in human serum and plasma
Enzyme Immunoassay for the quantitative determination of Nilotinib in serum, plasma and cell culture supernatant
Enzyme Immunoassay for the Quantitative Determination of Dasatinib in human serum and plasma
